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ABSTRACT 
Background: There is a high risk of bleeding complications in cardiac surgery. Fibrin-
ogen and platelet concentrates are often used to treat perioperative bleeding, but there 
is little information about its efficacy. The overall aim of this thesis project was to study 
the effects of fibrinogen, platelet and factor XIII concentrates on markers of hemostasis 
in blood samples from cardiac surgery patients.  
Methods: Increasing doses of fibrinogen, platelets, and factor XIII were added to blood 
samples from patients or healthy volunteers (study I, III–V). In study II, blood samples 
from cardiac surgery patients with ongoing bleeding were analyzed before and after trans-
fusion of fibrinogen and/or platelet concentrates. In all studies, platelet function was 
assessed with impedance aggregometry, and clot formation with thromboelastometry.  
Results: Supplementation with fibrinogen improved clot formation while platelets im-
proved both platelet aggregation and clot formation in blood samples form cardiac sur-
gery patients (I). Fibrinogen to patients with ongoing bleeding improved clot formation 
and platelets improved platelet aggregation (II). Factor XIII supplementation to blood 
samples from cardiac and scoliosis surgery patients improved clot formation moderately 
(III). Supplementation with platelets improved platelet aggregation independently of an-
tiplatelet therapy (IV). Time-dependent changes in platelet concentrates were detected 
with impedance aggregometry in vitro (V). The results predicted with moderate accuracy 
changes in aggregation after addition of the platelet concentrates to whole blood samples. 
Conclusions: The results suggest that transfusion with fibrinogen or platelets improve 
hemostasis, whereas factor XIII should remain a secondary tool in the treatment of peri-
operative bleeding. Impedance aggregometry may be used to monitor the quality of stored 
platelet concentrates in vitro. 
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